{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:12:54Z","timestamp":1783102374064,"version":"3.54.6"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100000125","name":"National Institute for Occupational Safety and Health","doi-asserted-by":"publisher","award":["CDC\/NIOSH 200-2011-39361"],"award-info":[{"award-number":["CDC\/NIOSH 200-2011-39361"]}],"id":[{"id":"10.13039\/100000125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 049953"],"award-info":[{"award-number":["R01 049953"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P50 AG005138"],"award-info":[{"award-number":["P50 AG005138"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s40120-020-00189-1","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T04:06:08Z","timestamp":1588219568000},"page":"159-171","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Pathway Analysis for Plasma \u03b2-Amyloid, Tau and Neurofilament Light (ATN) in World Trade Center Responders at Midlife"],"prefix":"10.1007","volume":"9","author":[{"given":"Minos","family":"Kritikos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean A. P.","family":"Clouston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica D.","family":"Diminich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Deri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Gandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn J.","family":"Bromet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Luft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,30]]},"reference":[{"issue":"5","key":"189_CR1","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/jts.22219","volume":"30","author":"SAP Clouston","year":"2017","unstructured":"Clouston SAP, Guralnik JM, Kotov R, Bromet EJ, Luft BJ. Functional limitations among responders to the world trade center attacks 14 years after the disaster: implications of chronic posttraumatic stress disorder. J Trauma Stress. 2017;30(5):443\u201352.","journal-title":"J Trauma Stress"},{"issue":"4","key":"189_CR2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.dadm.2016.08.001","volume":"2016","author":"SA Clouston","year":"2016","unstructured":"Clouston SA, Kotov R, Pietrzak RH, Luft BJ, Gonzalez A, Richards M, et al. Cognitive impairment among World Trade Center responders: long-term implications of re-experiencing the 9\/11 terrorist attacks. Alzheimers Dement (Amst). 2016;2016(4):67\u201375.","journal-title":"Alzheimers Dement (Amst)."},{"issue":"4","key":"189_CR3","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.trci.2017.08.007","volume":"3","author":"SAP Clouston","year":"2017","unstructured":"Clouston SAP, Shapira O, Kotov R, Lei L, Waszczuk M, Bromet EJ, et al. Proton pump inhibitors and the risk of severe cognitive impairment: the role of posttraumatic stress disorder. Alzheimers Dement (N Y). 2017;3(4):579\u201383.","journal-title":"Alzheimers Dement (N Y)."},{"issue":"7","key":"189_CR4","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.3390\/ijerph16071128","volume":"16","author":"S Mukherjee","year":"2019","unstructured":"Mukherjee S, Clouston S, Kotov R, Bromet E, Luft B. Handgrip strength of World Trade Center (WTC) responders: the role of re-experiencing posttraumatic stress disorder (PTSD) symptoms. Int J Environ Res Public Health. 2019;16(7):1128.","journal-title":"Int J Environ Res Public Health."},{"issue":"13","key":"189_CR5","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1056\/NEJMsa013404","volume":"346","author":"S Galea","year":"2002","unstructured":"Galea S, Ahern J, Resnick H, Kilpatrick D, Bucuvalas M, Gold J, et al. Psychological sequelae of the September 11 terrorist attacks in New York City. N Engl J Med. 2002;346(13):982\u20137.","journal-title":"N Engl J Med."},{"key":"189_CR6","first-page":"216","volume":"11","author":"S Clouston","year":"2019","unstructured":"Clouston S, Deri Y, Diminich E, Kew RR, Kotov R, Stewart C, et al. Posttraumatic stress disorder associated with total amyloid burden and amyloid-\u03b2 42\/40 ratios in plasma: results from a pilot study of World Trade Center responders. Alzheimer\u2019s Dement. 2019;11:216\u201320.","journal-title":"Alzheimer\u2019s Dement."},{"issue":"4","key":"189_CR7","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.trci.2017.09.001","volume":"3","author":"S Clouston","year":"2017","unstructured":"Clouston S, Pietrzak RH, Kotov R, Richards M, Spiro A 3rd, Scott S, et al. Traumatic exposures, posttraumatic stress disorder, and cognitive functioning in World Trade Center responders. Alzheimers Dement (N Y). 2017;3(4):593\u2013602.","journal-title":"Alzheimers Dement (N Y)."},{"key":"189_CR8","unstructured":"Clouston S, Kotov R, Pietrzak R, Richards M, Spiro III A, Mukherjee S, et al. Excess incidence of mild cognitive impairment in World Trade Center responders: evidence from a longitudinal study of cognitive functioning. Manuscript submitted for publication (copy on file with author)."},{"issue":"4","key":"189_CR9","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jalz.2018.03.002","volume":"14","author":"DS Knopman","year":"2018","unstructured":"Knopman DS, Haeberlein SB, Carrillo MC, Hendrix JA, Kerchner G, Margolin R, et al. The National Institute on Aging and the Alzheimer\u2019s Association Research Framework for Alzheimer\u2019s disease: perspectives from the research roundtable. Alzheimers Dement. 2018;14(4):563\u201375.","journal-title":"Alzheimers Dement."},{"issue":"3","key":"189_CR10","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):280\u201392.","journal-title":"Alzheimers Dement."},{"issue":"4","key":"189_CR11","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362.","journal-title":"Alzheimers Dement."},{"issue":"3","key":"189_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jalz.2018.02.001","volume":"14","author":"Alzheimer\u2019s Association","year":"2018","unstructured":"Alzheimer\u2019s Association. 2018 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement. 2018;14(3):367\u2013429.","journal-title":"Alzheimer\u2019s Dement."},{"issue":"5","key":"189_CR13","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/ana.25346","volume":"84","author":"P Vemuri","year":"2018","unstructured":"Vemuri P, Lesnick TG, Przybelski SA, Graff-Radford J, Reid RI, Lowe VJ, et al. Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging. Ann Neurol. 2018;84(5):705\u201316.","journal-title":"Ann Neurol"},{"issue":"3","key":"189_CR14","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1523\/JNEUROSCI.2028-17.2017","volume":"38","author":"A Maass","year":"2018","unstructured":"Maass A, Lockhart SN, Harrison TM, Bell RK, Mellinger T, Swinnerton K, et al. Entorhinal tau pathology, episodic memory decline, and neurodegeneration in aging. J Neurosci. 2018;38(3):530\u201343.","journal-title":"J Neurosci"},{"key":"189_CR15","doi-asserted-by":"publisher","first-page":"d7622","DOI":"10.1136\/bmj.d7622","volume":"344","author":"A Singh-Manoux","year":"2012","unstructured":"Singh-Manoux A, Kivimaki M, Glymour MM, Elbaz A, Berr C, Ebmeier KP, et al. Timing of onset of cognitive decline: results from Whitehall II prospective cohort study. BMJ. 2012;344:d7622.","journal-title":"BMJ"},{"issue":"5","key":"189_CR16","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/ajhb.21057","volume":"22","author":"RW Nahhas","year":"2010","unstructured":"Nahhas RW, Choh AC, Lee M, Chumlea WM, Duren DL, Siervogel RM, et al. Bayesian longitudinal plateau model of adult grip strength. Am J Hum Biol. 2010;22(5):648\u201356.","journal-title":"Am J Hum Biol."},{"issue":"7691","key":"189_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature25456","volume":"554","author":"A Nakamura","year":"2018","unstructured":"Nakamura A, Kaneko N, Villemagne VL, Kato T, Doecke J, Dore V, et al. High performance plasma amyloid-beta biomarkers for Alzheimer\u2019s disease. Nature. 2018;554(7691):249\u201354.","journal-title":"Nature"},{"issue":"1","key":"189_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2174\/187152709787601867","volume":"8","author":"R Deane","year":"2009","unstructured":"Deane R, Bell RD, Sagare A, Zlokovic BV. Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer\u2019s disease. CNS Neurol Disord Drug Targets. 2009;8(1):16\u201330.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"189_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fneur.2013.00083","volume":"4","author":"W Noble","year":"2013","unstructured":"Noble W, Hanger DP, Miller CC, Lovestone S. The importance of tau phosphorylation for neurodegenerative diseases. Front Neurol. 2013;4:83.","journal-title":"Front Neurol."},{"issue":"17","key":"189_CR20","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1212\/WNL.0000000000003246","volume":"87","author":"N Mattsson","year":"2016","unstructured":"Mattsson N, Zetterberg H, Janelidze S, Insel PS, Andreasson U, Stomrud E, et al. Plasma tau in Alzheimer disease. Neurology. 2016;87(17):1827\u201335.","journal-title":"Neurology."},{"issue":"7","key":"189_CR21","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","volume":"76","author":"N Mattsson","year":"2019","unstructured":"Mattsson N, Cullen NC, Andreasson U, Zetterberg H, Blennow K. Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease. JAMA Neurol. 2019;76(7):791\u20139.","journal-title":"JAMA Neurol."},{"issue":"10","key":"189_CR22","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1212\/WNL.0000000000003688","volume":"88","author":"P Steinacker","year":"2017","unstructured":"Steinacker P, Semler E, Anderl-Straub S, Diehl-Schmid J, Schroeter ML, Uttner I, et al. Neurofilament as a blood marker for diagnosis and monitoring of primary progressive aphasias. Neurology. 2017;88(10):961\u20139.","journal-title":"Neurology."},{"issue":"10","key":"189_CR23","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1515\/cclm-2015-1195","volume":"54","author":"J Kuhle","year":"2016","unstructured":"Kuhle J, Barro C, Andreasson U, Derfuss T, Lindberg R, Sandelius A, et al. Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa. Clin Chem Lab Med. 2016;54(10):1655\u201361.","journal-title":"Clin Chem Lab Med"},{"key":"189_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ebiom.2015.11.036","volume":"3","author":"M Gisslen","year":"2016","unstructured":"Gisslen M, Price RW, Andreasson U, Norgren N, Nilsson S, Hagberg L, et al. Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: a cross-sectional study. EBioMedicine. 2016;3:135\u201340.","journal-title":"EBioMedicine."},{"key":"189_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fnins.2018.00025","volume":"12","author":"F Kametani","year":"2018","unstructured":"Kametani F, Hasegawa M. Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer\u2019s disease. Front Neurosci. 2018;12:25.","journal-title":"Front Neurosci."},{"issue":"2","key":"189_CR26","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1093\/ije\/dyv099","volume":"46","author":"CR Dasaro","year":"2017","unstructured":"Dasaro CR, Holden WL, Berman KD, Crane MA, Kaplan JR, Lucchini RG, et al. Cohort profile: World Trade Center health program general responder cohort. Int J Epidemiol. 2017;46(2):e9.","journal-title":"Int J Epidemiol"},{"key":"189_CR27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.dadm.2016.08.001","volume":"4","author":"SA Clouston","year":"2016","unstructured":"Clouston SA, Kotov R, Pietrzak RH, Luft BJ, Gonzalez A, Richards M, et al. Cognitive impairment among World Trade Center responders: long-term implications of re-experiencing the 9\/11 terrorist attacks. Alzheimers Dement (Amst). 2016;4:67\u201375.","journal-title":"Alzheimers Dement (Amst)."},{"key":"189_CR28","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.dadm.2019.07.006","volume":"11","author":"SAP Clouston","year":"2019","unstructured":"Clouston SAP, Diminich ED, Kotov R, Pietrzak RH, Richards M, Spiro A 3rd, et al. Incidence of mild cognitive impairment in World Trade Center responders: long-term consequences of re-experiencing the events on 9\/11\/2001. Alzheimers Dement (Amst). 2019;11:628\u201336.","journal-title":"Alzheimers Dement (Amst)."},{"key":"189_CR29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.dadm.2017.07.004","volume":"8","author":"N Fandos","year":"2017","unstructured":"Fandos N, P\u00e9rez-Grijalba V, Pesini P, Olmos S, Bossa M, Villemagne VL, et al. Plasma amyloid \u03b2 42\/40 ratios as biomarkers for amyloid \u03b2 cerebral deposition in cognitively normal individuals. Alzheimers Dement (Amst). 2017;8:179\u201387.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"4","key":"189_CR30","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695\u20139.","journal-title":"J Am Geriatr Soc"},{"key":"189_CR31","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.dadm.2018.04.003","volume":"10","author":"JA Elman","year":"2018","unstructured":"Elman JA, Jak AJ, Panizzon MS, Tu XM, Chen T, Reynolds CA, et al. Underdiagnosis of mild cognitive impairment: a consequence of ignoring practice effects. Alzheimers Dement (Amst). 2018;10:372\u201381.","journal-title":"Alzheimers Dement (Amst)."},{"issue":"2","key":"189_CR32","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/gps.4756","volume":"33","author":"N Carson","year":"2018","unstructured":"Carson N, Leach L, Murphy KJ. A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores. Int J Geriatr Psychiatry. 2018;33(2):379\u201388.","journal-title":"Int J Geriatr Psychiatry."},{"key":"189_CR33","doi-asserted-by":"publisher","DOI":"10.1201\/9780203489437","volume-title":"Generalized latent variable modeling: multilevel, longitudinal, and structural equation models","author":"A Skrondal","year":"2004","unstructured":"Skrondal A, Rabe-Hesketh S. Generalized latent variable modeling: multilevel, longitudinal, and structural equation models. Boca Raton: CRC; 2004."},{"issue":"3","key":"189_CR34","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1037\/0033-2909.118.3.392","volume":"118","author":"W Gardner","year":"1995","unstructured":"Gardner W, Mulvey EP, Shaw EC. Regression analyses of counts and rates: Poisson, overdispersed Poisson, and negative binomial models. Psychol Bull. 1995;118(3):392\u2013404.","journal-title":"Psychol Bull"},{"issue":"10","key":"189_CR35","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/aje\/kwg074","volume":"157","author":"LA McNutt","year":"2003","unstructured":"McNutt LA, Wu C, Xue X, Hafner JP. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol. 2003;157(10):940\u20133.","journal-title":"Am J Epidemiol"},{"issue":"17","key":"189_CR36","doi-asserted-by":"publisher","first-page":"4959","DOI":"10.7150\/thno.35366","volume":"9","author":"M Liu","year":"2019","unstructured":"Liu M, Paranjpe MD, Zhou X, Duy PQ, Goyal MS, Benzinger TLS, et al. Sex modulates the ApoE epsilon 4 effect on brain tau deposition measured by (18)F-AV-1451 PET in individuals with mild cognitive impairment. Theranostics. 2019;9(17):4959\u201370.","journal-title":"Theranostics."},{"key":"189_CR37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13195-018-0395-6","volume":"10","author":"S Hilal","year":"2018","unstructured":"Hilal S, Wolters FJ, Verbeek MM, Vanderstichele H, Kamran Ikram M, Stoops E, et al. Plasma amyloid-\u03b2 levels, cerebral atrophy and risk of dementia: a population-based study. Alzheimers Res Ther. 2018;10:63.","journal-title":"Alzheimers Res Ther."},{"issue":"6","key":"189_CR38","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.jalz.2019.03.009","volume":"15","author":"A Vergallo","year":"2019","unstructured":"Vergallo A, M\u00e9gret L, Lista S, Cavedo E, Zetterberg H, Blennow K, et al. Plasma amyloid \u03b2 40\/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2019;15(6):764\u201375.","journal-title":"Alzheimer\u2019s Dement."},{"issue":"3","key":"189_CR39","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1046\/j.1365-2990.1998.00112.x","volume":"24","author":"DM Mann","year":"1998","unstructured":"Mann DM, Brown SM, Owen F, Baba M, Iwatsubo T. Amyloid beta protein (A beta) deposition in dementia with Lewy bodies: predominance of A beta 42(43) and paucity of A beta 40 compared with sporadic Alzheimer\u2019s disease. Neuropathol Appl Neurobiol. 1998;24(3):187\u201394.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"189_CR40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0306-4522(01)00169-5","volume":"105","author":"TC Dickson","year":"2001","unstructured":"Dickson TC, Vickers JC. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer\u2019s disease. Neuroscience. 2001;105(1):99\u2013107.","journal-title":"Neuroscience"},{"issue":"2","key":"189_CR41","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0006-8993(94)91136-3","volume":"648","author":"N Selden","year":"1994","unstructured":"Selden N, Mesulam MM, Geula C. Human striatum: the distribution of neurofibrillary tangles in Alzheimer\u2019s disease. Brain Res. 1994;648(2):327\u201331.","journal-title":"Brain Res"},{"issue":"6","key":"189_CR42","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1212\/WNL.0b013e3181cef7e3","volume":"74","author":"JV Ly","year":"2010","unstructured":"Ly JV, Donnan GA, Villemagne VL, Zavala JA, Ma H, O\u2019Keefe G, et al. 11C-PIB binding is increased in patients with cerebral amyloid angiopathy-related hemorrhage. Neurology. 2010;74(6):487\u201393.","journal-title":"Neurology."},{"issue":"2","key":"189_CR43","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/ana.24711","volume":"80","author":"H Cho","year":"2016","unstructured":"Cho H, Choi JY, Hwang MS, Kim YJ, Lee HM, Lee HS, et al. In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum. Ann Neurol. 2016;80(2):247\u201358.","journal-title":"Ann Neurol"},{"key":"189_CR44","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.dadm.2019.01.003","volume":"11","author":"SAP Clouston","year":"2019","unstructured":"Clouston SAP, Deri Y, Diminich E, Kew R, Kotov R, Stewart C, et al. Posttraumatic stress disorder and total amyloid burden and amyloid-beta 42\/40 ratios in plasma: results from a pilot study of World Trade Center responders. Alzheimers Dement (Amst). 2019;11:216\u201320.","journal-title":"Alzheimers Dement (Amst)."},{"issue":"8","key":"189_CR45","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jalz.2018.02.013","volume":"14","author":"MM Mielke","year":"2018","unstructured":"Mielke MM, Hagen CE, Xu J, Chai X, Vemuri P, Lowe VJ, et al. Plasma phospho-tau181 increases with Alzheimer\u2019s disease clinical severity and is associated with tau- and amyloid-positron emission tomography. Alzheimers Dement. 2018;14(8):989\u201397.","journal-title":"Alzheimers Dement."},{"key":"189_CR46","unstructured":"Clouston SAP, Deri Y, Horton M, Tang C, Diminich E, DeLorenzo C, et al. Reduced cortical thickness in World Trade Center responders with cognitive impairment. Manuscript submitted for publication (copy on file with author)."},{"key":"189_CR47","unstructured":"Clouston S, Diminich E, Kranidis A, Kotov R, Kuan PF, Bromet E, et al. Posttraumatic stress-related cognitive and physical impairment: clinical characterization of a novel disorder. Manuscript submitted for publication (copy on file with author)."},{"issue":"6","key":"189_CR48","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","volume":"128","author":"JF Crary","year":"2014","unstructured":"Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, et al. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol. 2014;128(6):755\u201366.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"189_CR49","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nrneurol.2015.251","volume":"12","author":"CR Jack Jr","year":"2016","unstructured":"Jack CR Jr, Knopman DS, Chetelat G, Dickson D, Fagan AM, Frisoni GB, et al. Suspected non-Alzheimer disease pathophysiology-concept and controversy. Nat Rev Neurol. 2016;12(2):117\u201324.","journal-title":"Nat Rev Neurol."}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-020-00189-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-020-00189-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-020-00189-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:14:45Z","timestamp":1619741685000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-020-00189-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,30]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["189"],"URL":"https:\/\/doi.org\/10.1007\/s40120-020-00189-1","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,30]]},"assertion":[{"value":"23 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}